Column GROUP Gp, L.P., 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 225,103 shares at $10.79 ($2.5M) on 2022-05-09, disclosed to the SEC on 2022-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.79 | 2,745 | $30K | 1.2% |
| 2 | $10.79 | 80,430 | $868K | 35.2% |
| 3 | $10.79 | 80,430 | $868K | 35.2% |
| 4 | $11.36 | 1,032 | $12K | 0.5% |
| 5 | $11.36 | 30,233 | $343K | 13.9% |
| 6 | $11.36 | 30,233 |
| $343K |
| 13.9% |
| Total | $10.95 avg | 225,103 | $2.5M | 100% |
| Filing → |
| NGM | BUY | 2022-06-02 | $4.1M | — | Filing → |
| NGM | BUY | 2019-11-13 | $180 | — | Filing → |
| CNST | BUY | 2019-10-07 | $12.0M | — | Filing → |